MOLINELLI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 7.585
AS - Asia 3.335
EU - Europa 3.230
SA - Sud America 694
Continente sconosciuto - Info sul continente non disponibili 359
AF - Africa 238
OC - Oceania 6
Totale 15.447
Nazione #
US - Stati Uniti d'America 7.417
SG - Singapore 1.050
IT - Italia 831
VN - Vietnam 772
CN - Cina 682
RU - Federazione Russa 611
BR - Brasile 548
HK - Hong Kong 333
FR - Francia 276
IE - Irlanda 264
SE - Svezia 245
DE - Germania 231
UA - Ucraina 177
GB - Regno Unito 164
FI - Finlandia 148
IN - India 104
CI - Costa d'Avorio 100
BD - Bangladesh 84
CA - Canada 84
NL - Olanda 62
TR - Turchia 57
ZA - Sudafrica 55
AR - Argentina 53
MX - Messico 49
DK - Danimarca 47
JP - Giappone 44
MA - Marocco 42
ES - Italia 34
IQ - Iraq 34
AT - Austria 32
PL - Polonia 29
EC - Ecuador 27
ID - Indonesia 26
KR - Corea 25
UZ - Uzbekistan 19
BE - Belgio 18
VE - Venezuela 15
CL - Cile 14
CO - Colombia 14
PH - Filippine 14
PK - Pakistan 13
TH - Thailandia 12
LT - Lituania 10
PY - Paraguay 10
CZ - Repubblica Ceca 9
JM - Giamaica 9
SA - Arabia Saudita 9
EG - Egitto 8
GR - Grecia 8
KE - Kenya 8
MY - Malesia 8
TN - Tunisia 8
PE - Perù 7
CR - Costa Rica 6
DZ - Algeria 6
NP - Nepal 6
AU - Australia 5
AZ - Azerbaigian 5
IL - Israele 5
TW - Taiwan 5
PA - Panama 4
PS - Palestinian Territory 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EU - Europa 3
HR - Croazia 3
HU - Ungheria 3
JO - Giordania 3
KG - Kirghizistan 3
OM - Oman 3
PT - Portogallo 3
AL - Albania 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
KZ - Kazakistan 2
LY - Libia 2
QA - Qatar 2
SM - San Marino 2
AI - Anguilla 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
EE - Estonia 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 15.076
Città #
Ashburn 1.373
Singapore 665
Chandler 620
Dallas 499
San Jose 425
Council Bluffs 394
Hong Kong 322
Des Moines 315
Boardman 264
Ho Chi Minh City 258
Dublin 255
Fairfield 233
New York 213
Jacksonville 192
The Dalles 179
Hanoi 177
Los Angeles 162
Beijing 144
Seattle 120
Lauterbourg 114
Moscow 110
Wilmington 108
Houston 101
Abidjan 99
Woodbridge 93
Munich 92
Helsinki 89
Lawrence 82
Princeton 82
Cambridge 73
Milan 70
Ann Arbor 62
San Mateo 62
Ancona 59
Centro 57
Chicago 54
Hefei 54
Buffalo 53
São Paulo 53
London 52
Santa Clara 50
Da Nang 47
Orem 44
Turin 41
San Diego 40
Haiphong 39
Rome 38
Turku 38
Washington 38
Johannesburg 37
Shanghai 35
Pune 33
Tokyo 32
Brooklyn 31
Boydton 29
Guangzhou 29
Montreal 27
Denver 26
San Francisco 26
Warsaw 25
Wuhan 25
Chennai 23
Columbus 23
Nuremberg 23
Phoenix 22
Atlanta 19
Brussels 18
Amsterdam 17
Stockholm 17
Manchester 16
Urbisaglia 16
Vienna 16
Frankfurt am Main 15
Hải Dương 15
Tolentino 15
Toronto 15
Elk Grove Village 14
Marche 14
Miano 14
Naples 14
Baghdad 13
Boston 13
Rio de Janeiro 13
Salt Lake City 13
Tashkent 13
Biên Hòa 12
Piscataway 12
Poplar 12
Curitiba 11
Mexico City 11
Porto Alegre 11
Charlotte 10
Kazan' 10
Mumbai 10
Quito 10
Cape Town 9
Civitanova Marche 9
Guayaquil 9
Menlo Park 9
Perugia 9
Totale 9.704
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 331
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 242
Melanoma e tessuto adiposo peritumorale: studio preliminare sul ruolo delle adipocitochine nella caratterizzazione e prognosi di malattia 205
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review 194
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 187
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. 182
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 171
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 170
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile 161
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 160
Differential expression of nicotinamide n-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study 158
Oxidative stress and alterations of paraoxonases in atopic dermatitis 158
Involvement of the oral cavity in psoriasis: results of a clinical study 156
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 156
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways 153
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 152
Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts 151
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 150
MiR-146a-5p correlates with clinical efficacy in psoriasis patients treated with the TNF alpha inhibitor Adalimumab 148
Biologic Therapy in Psoriasis: Safety Profile 147
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 144
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 144
Bimekizumab: dual inhibition as a promising tool in the management of hidradenitis suppurativa 143
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 143
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 142
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art 141
Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: A controlled prospective clinical study 141
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 140
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 140
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 136
Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review 135
Review: A safety profile of dalbavancin for onand off-label utilization 135
Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma 135
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 135
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 134
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 132
Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma 132
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 130
Efficacy of oral zinc and nicotinamide as maintenance therapy for mild/moderate hidradenitis suppurativa: A controlled retrospective clinical study 130
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 130
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 129
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 128
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 128
Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review 127
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone 127
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 127
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 126
Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. 124
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 124
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 123
Biological treatments for pediatric psoriasis: state of the art and future perspectives 122
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines 122
Reticulated acanthoma with sebaceous differentiation 122
Kaposi-Juliusberg varicelliform eruption in patient suffering from Darier-White disease: a case report and review of the literature 122
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 122
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 121
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 121
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- alpha Inhibitors 120
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 120
The Role of Diet in Children with Psoriasis: Emerging Evidence and Current Issues 119
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints 119
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis 119
Relapsing acute generalized exanthematous pustolosis: a guess. 119
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 119
Topical application of fumaric acid esters improves appearance of nail psoriasis 117
Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study 116
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 116
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 116
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 114
Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review 114
Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata 114
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 113
The sources of antimicrobial peptides against Gram-positives and Gramnegatives: our research experience 113
CT patterns of interstitial lung disease in patients with plaque psoriasis: a retrospective case series study 113
Mycosis Fungoides-like Eruption and Infliximab 113
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 113
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 113
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 111
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 110
IL-17, IL-23, and p73 expression in cutaneous melanoma: a pilot study 109
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 109
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 109
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 108
Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma 107
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group 107
Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review 106
Atypical Scleroderma-like Chronic GVHD in a Liver Transplant Patient, Clinical and MRI Correlations 106
Immunohistochemical expression of nicotinamide N-methyltransferase in cutaneous basal and squamous cell carcinomas 105
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa 103
Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi 103
Bimekizumab in hidradenitis suppurativa: a valid and rapid emerging treatment 102
Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues 101
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma 101
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 101
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 99
Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis. 98
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel 98
Role of daptomycin in cutaneous wound healing: a narrative review 97
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 97
Sneddon-Wilkinson disease and monoclonal gammopathy of undetermined significance in the elderly: Case report 97
Totale 13.093
Categoria #
all - tutte 75.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.031


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022676 0 100 27 12 29 46 25 53 47 28 137 172
2022/20231.897 132 187 122 176 114 474 8 103 381 10 130 60
2023/20241.281 160 24 150 135 165 293 27 71 19 85 16 136
2024/20252.399 315 179 75 37 99 98 234 94 499 168 316 285
2025/20267.136 561 409 548 694 739 489 1.364 599 581 596 249 307
2026/2027520 349 171 0 0 0 0 0 0 0 0 0 0
Totale 15.447